CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

April 15, 2020 · PDUFA decision

URGN PDUFA decision: a negative outcome, -14.7%

On April 15, 2020, UroGen Pharma Ltd. reached its PDUFA decision. The result was a negative outcome, and the stock moved -14.7% in the window around the event. It had already run +45.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$24.67
1d before
$21.04
Event day
$22.14
1d after
$23.30
5d after

Pre-catalyst setup

+45.7%
30-day run-up
10679%
30-day volatility